Assessment of humoral immunity to SARS-CoV-2 and other infectious agents is typically restricted to detecting
antigen-specific
antibodies in the serum. Rarely does immune monitoring entail assessment of the memory B-cell compartment itself, although it is these cells that engage in secondary antibody responses capable of mediating immune protection when pre-existing
antibodies fail to prevent
re-infection. There are few techniques that are capable of detecting rare
antigen-specific B cells while also providing information regarding their relative abundance, class/subclass usage and functional affinity. In theory, the ELISPOT/FluoroSpot (collectively ImmunoSpot) assay platform is ideally suited for
antigen-specific B-cell assessments since it provides this information at single-cell resolution for individual antibody-secreting cells (ASC). Here, we tested the hypothesis that
antigen-coating efficiency could be universally improved across a diverse set of
viral antigens if the standard direct (non-specific, low affinity)
antigen absorption to the membrane was substituted by high-affinity capture. Specifically, we report an enhancement in assay sensitivity and a reduction in required
protein concentrations through the capture of
recombinant proteins via their encoded
hexahistidine (6XHis) affinity tag. Affinity tag
antigen coating enabled detection of SARS-CoV-2 Spike receptor binding domain (RBD)-reactive ASC, and also significantly improved assay performance using additional control
antigens. Collectively, establishment of a universal
antigen-coating approach streamlines characterization of the memory B-cell compartment after
SARS-CoV-2 infection or
COVID-19 vaccinations, and facilitates high-throughput immune-monitoring efforts of large donor cohorts in general.